| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bacteriophages | 9 | 2013 | 24 | 1.870 |
Why?
|
| Candida albicans | 12 | 2012 | 38 | 1.840 |
Why?
|
| Yersinia pestis | 3 | 2012 | 6 | 1.170 |
Why?
|
| Genes, Reporter | 7 | 2013 | 191 | 1.020 |
Why?
|
| Luminescent Measurements | 4 | 2013 | 58 | 1.010 |
Why?
|
| Candidiasis | 7 | 2007 | 39 | 0.900 |
Why?
|
| Bacillus anthracis | 3 | 2013 | 11 | 0.850 |
Why?
|
| Luminescent Agents | 2 | 2009 | 11 | 0.680 |
Why?
|
| Gastrointestinal Microbiome | 4 | 2022 | 121 | 0.650 |
Why?
|
| Plague | 3 | 2012 | 9 | 0.560 |
Why?
|
| Drug Resistance, Bacterial | 2 | 2013 | 98 | 0.490 |
Why?
|
| Germ-Free Life | 7 | 2022 | 12 | 0.490 |
Why?
|
| Tongue | 2 | 2012 | 20 | 0.420 |
Why?
|
| Laser Capture Microdissection | 1 | 2012 | 3 | 0.410 |
Why?
|
| Anti-Bacterial Agents | 3 | 2023 | 1026 | 0.410 |
Why?
|
| Osteoclasts | 3 | 2022 | 132 | 0.410 |
Why?
|
| Bacteriological Techniques | 1 | 2012 | 49 | 0.410 |
Why?
|
| Killer Cells, Natural | 2 | 2007 | 94 | 0.360 |
Why?
|
| Mouth | 3 | 2022 | 64 | 0.360 |
Why?
|
| Homeostasis | 4 | 2022 | 291 | 0.350 |
Why?
|
| Mice | 22 | 2023 | 8474 | 0.350 |
Why?
|
| Bacillus Phages | 1 | 2009 | 1 | 0.340 |
Why?
|
| Membrane Glycoproteins | 6 | 2017 | 370 | 0.330 |
Why?
|
| Bone and Bones | 2 | 2021 | 145 | 0.330 |
Why?
|
| Virulence | 3 | 2007 | 51 | 0.330 |
Why?
|
| T-Lymphocytes | 3 | 2021 | 597 | 0.320 |
Why?
|
| Esophagus | 2 | 2007 | 303 | 0.320 |
Why?
|
| Candida glabrata | 1 | 2007 | 3 | 0.310 |
Why?
|
| Mouth Mucosa | 1 | 2007 | 51 | 0.300 |
Why?
|
| Gastric Mucosa | 1 | 2007 | 77 | 0.300 |
Why?
|
| Saccharomyces cerevisiae Proteins | 3 | 2012 | 123 | 0.290 |
Why?
|
| Mice, Inbred C57BL | 12 | 2023 | 2791 | 0.290 |
Why?
|
| Microbiota | 3 | 2017 | 79 | 0.280 |
Why?
|
| Specific Pathogen-Free Organisms | 3 | 2022 | 32 | 0.280 |
Why?
|
| Culture Media, Conditioned | 1 | 2005 | 78 | 0.260 |
Why?
|
| Animals | 23 | 2023 | 20880 | 0.250 |
Why?
|
| DNA, Bacterial | 3 | 2017 | 150 | 0.240 |
Why?
|
| Genetic Therapy | 3 | 2003 | 291 | 0.240 |
Why?
|
| Mannose | 2 | 2004 | 9 | 0.240 |
Why?
|
| Bacterial Infections | 2 | 2003 | 163 | 0.240 |
Why?
|
| Bacterial Proteins | 3 | 2011 | 244 | 0.230 |
Why?
|
| Osteogenesis | 2 | 2023 | 152 | 0.230 |
Why?
|
| Antioxidants | 1 | 2005 | 304 | 0.220 |
Why?
|
| Bacterial Toxins | 1 | 2003 | 50 | 0.220 |
Why?
|
| Escherichia coli Proteins | 1 | 2003 | 64 | 0.220 |
Why?
|
| Gastrointestinal Tract | 2 | 2017 | 63 | 0.210 |
Why?
|
| Plant Diseases | 2 | 2012 | 10 | 0.210 |
Why?
|
| Pseudomonas | 2 | 2012 | 8 | 0.210 |
Why?
|
| Minocycline | 1 | 2023 | 61 | 0.210 |
Why?
|
| Transformation, Genetic | 1 | 2002 | 14 | 0.210 |
Why?
|
| Saccharomyces cerevisiae | 3 | 2012 | 172 | 0.200 |
Why?
|
| Gram-Negative Bacteria | 1 | 2002 | 55 | 0.200 |
Why?
|
| DNA, Viral | 1 | 2002 | 114 | 0.200 |
Why?
|
| Dysbiosis | 1 | 2021 | 24 | 0.200 |
Why?
|
| Alveolar Bone Loss | 1 | 2021 | 40 | 0.200 |
Why?
|
| Recombination, Genetic | 3 | 2012 | 62 | 0.200 |
Why?
|
| Oxidative Stress | 1 | 2005 | 718 | 0.190 |
Why?
|
| Bacteroides fragilis | 1 | 2021 | 20 | 0.190 |
Why?
|
| Cell Wall | 2 | 2004 | 21 | 0.190 |
Why?
|
| Phylogeny | 2 | 2017 | 196 | 0.180 |
Why?
|
| Bacteria | 2 | 2021 | 193 | 0.180 |
Why?
|
| Fungal Proteins | 4 | 2007 | 37 | 0.170 |
Why?
|
| Antifungal Agents | 1 | 1999 | 108 | 0.160 |
Why?
|
| Graft vs Host Disease | 1 | 2021 | 163 | 0.160 |
Why?
|
| Membrane Proteins | 1 | 2003 | 617 | 0.160 |
Why?
|
| Gene Expression Regulation, Fungal | 4 | 2007 | 31 | 0.160 |
Why?
|
| Tooth Eruption | 1 | 2017 | 1 | 0.150 |
Why?
|
| Promoter Regions, Genetic | 4 | 2007 | 614 | 0.150 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2017 | 85 | 0.150 |
Why?
|
| CD11c Antigen | 1 | 2017 | 18 | 0.150 |
Why?
|
| Mannosyltransferases | 3 | 2004 | 4 | 0.150 |
Why?
|
| Bone Marrow | 1 | 2017 | 168 | 0.140 |
Why?
|
| Cytokines | 4 | 2017 | 866 | 0.140 |
Why?
|
| Liver | 2 | 2023 | 1118 | 0.140 |
Why?
|
| DNA-Binding Proteins | 2 | 2012 | 700 | 0.140 |
Why?
|
| Chemokines | 2 | 2007 | 119 | 0.130 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2017 | 199 | 0.130 |
Why?
|
| Inflammation | 2 | 2014 | 1030 | 0.130 |
Why?
|
| Thioacetamide | 1 | 2014 | 2 | 0.130 |
Why?
|
| Intestines | 1 | 2015 | 114 | 0.130 |
Why?
|
| beta-Defensins | 2 | 2005 | 8 | 0.130 |
Why?
|
| Luciferases | 2 | 2012 | 105 | 0.120 |
Why?
|
| Protective Agents | 1 | 2014 | 36 | 0.120 |
Why?
|
| DNA Methylation | 1 | 2015 | 193 | 0.120 |
Why?
|
| Epigenesis, Genetic | 1 | 2015 | 163 | 0.120 |
Why?
|
| Stem Cells | 1 | 2015 | 248 | 0.120 |
Why?
|
| Hepatocytes | 1 | 2014 | 205 | 0.110 |
Why?
|
| Brassica | 1 | 2012 | 13 | 0.110 |
Why?
|
| Gene Expression Regulation, Bacterial | 2 | 2003 | 49 | 0.110 |
Why?
|
| Chromosomes, Fungal | 1 | 2012 | 14 | 0.110 |
Why?
|
| Gene Deletion | 3 | 2017 | 235 | 0.110 |
Why?
|
| Niacinamide | 1 | 2012 | 31 | 0.110 |
Why?
|
| Molecular Sequence Data | 9 | 2012 | 1446 | 0.100 |
Why?
|
| Brassicaceae | 1 | 2012 | 2 | 0.100 |
Why?
|
| Mice, Transgenic | 3 | 2017 | 1033 | 0.100 |
Why?
|
| Escherichia coli | 3 | 2003 | 368 | 0.100 |
Why?
|
| Luminescence | 1 | 2012 | 31 | 0.100 |
Why?
|
| Base Sequence | 6 | 2003 | 1015 | 0.100 |
Why?
|
| Anthrax | 1 | 2011 | 6 | 0.100 |
Why?
|
| Vibrio | 1 | 2011 | 14 | 0.100 |
Why?
|
| Host-Pathogen Interactions | 1 | 2012 | 69 | 0.100 |
Why?
|
| Liver Cirrhosis | 1 | 2014 | 301 | 0.100 |
Why?
|
| Cell Differentiation | 1 | 2015 | 1034 | 0.100 |
Why?
|
| Mice, Inbred BALB C | 3 | 2021 | 532 | 0.090 |
Why?
|
| Cell Adhesion | 3 | 2004 | 324 | 0.090 |
Why?
|
| Mice, Inbred CBA | 2 | 2007 | 107 | 0.090 |
Why?
|
| Plasmids | 3 | 2012 | 258 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2014 | 710 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 2 | 2009 | 492 | 0.090 |
Why?
|
| Disease Models, Animal | 5 | 2021 | 2550 | 0.090 |
Why?
|
| Luminescent Proteins | 1 | 2009 | 57 | 0.080 |
Why?
|
| Bacteriophage P1 | 3 | 2003 | 10 | 0.080 |
Why?
|
| Candidiasis, Oral | 1 | 2007 | 7 | 0.080 |
Why?
|
| Tropism | 1 | 2007 | 3 | 0.080 |
Why?
|
| Sensitivity and Specificity | 1 | 2012 | 1753 | 0.080 |
Why?
|
| Hyphae | 1 | 2007 | 4 | 0.080 |
Why?
|
| Granulocytes | 1 | 2007 | 22 | 0.080 |
Why?
|
| Stomach Diseases | 2 | 2005 | 22 | 0.080 |
Why?
|
| Paraoxon | 1 | 2007 | 4 | 0.080 |
Why?
|
| Gene Expression | 2 | 2007 | 770 | 0.070 |
Why?
|
| Genetic Engineering | 2 | 2007 | 41 | 0.070 |
Why?
|
| Biosensing Techniques | 1 | 2007 | 51 | 0.070 |
Why?
|
| Stomach | 2 | 2004 | 80 | 0.070 |
Why?
|
| Humans | 13 | 2014 | 68549 | 0.070 |
Why?
|
| Farnesol | 1 | 2005 | 2 | 0.070 |
Why?
|
| alpha-Tocopherol | 1 | 2005 | 5 | 0.070 |
Why?
|
| Vitamin K 3 | 1 | 2005 | 3 | 0.070 |
Why?
|
| Naphthoquinones | 1 | 2005 | 14 | 0.070 |
Why?
|
| Survival Analysis | 1 | 2007 | 714 | 0.070 |
Why?
|
| Oxidants | 1 | 2005 | 48 | 0.070 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2017 | 209 | 0.070 |
Why?
|
| Intestinal Mucosa | 2 | 2017 | 219 | 0.060 |
Why?
|
| Signal Transduction | 1 | 2014 | 2689 | 0.060 |
Why?
|
| Lipase | 1 | 2005 | 16 | 0.060 |
Why?
|
| Phagocytes | 1 | 2005 | 15 | 0.060 |
Why?
|
| Antifibrinolytic Agents | 1 | 2005 | 52 | 0.060 |
Why?
|
| DNA, Ribosomal | 2 | 2017 | 59 | 0.060 |
Why?
|
| Glycosylation | 3 | 2002 | 185 | 0.060 |
Why?
|
| Virulence Factors | 1 | 2004 | 11 | 0.060 |
Why?
|
| Hydrogen Peroxide | 1 | 2005 | 168 | 0.060 |
Why?
|
| NADPH Oxidases | 1 | 2005 | 80 | 0.060 |
Why?
|
| Antigens, Neoplasm | 2 | 2002 | 132 | 0.060 |
Why?
|
| Gastrointestinal Diseases | 1 | 2005 | 107 | 0.060 |
Why?
|
| Nitric Oxide Synthase | 1 | 2005 | 163 | 0.060 |
Why?
|
| Viral Proteins | 2 | 2003 | 149 | 0.060 |
Why?
|
| Repressor Proteins | 2 | 2003 | 182 | 0.060 |
Why?
|
| Immunocompetence | 1 | 2003 | 19 | 0.060 |
Why?
|
| Gram-Positive Cocci | 1 | 2003 | 5 | 0.060 |
Why?
|
| Mice, Inbred ICR | 1 | 2003 | 44 | 0.060 |
Why?
|
| Transcription Factors | 1 | 2007 | 753 | 0.060 |
Why?
|
| Bile Acids and Salts | 1 | 2023 | 19 | 0.050 |
Why?
|
| Anticoagulants | 1 | 2005 | 356 | 0.050 |
Why?
|
| Hot Temperature | 1 | 2003 | 152 | 0.050 |
Why?
|
| Bacteriophage M13 | 1 | 2002 | 12 | 0.050 |
Why?
|
| RNA, Messenger | 4 | 2014 | 1663 | 0.050 |
Why?
|
| Restriction Mapping | 1 | 2002 | 85 | 0.050 |
Why?
|
| Shigella flexneri | 1 | 2001 | 8 | 0.050 |
Why?
|
| Placenta | 2 | 2000 | 101 | 0.050 |
Why?
|
| Transduction, Genetic | 1 | 2002 | 81 | 0.050 |
Why?
|
| Klebsiella pneumoniae | 1 | 2001 | 18 | 0.050 |
Why?
|
| DNA Primers | 1 | 2002 | 302 | 0.050 |
Why?
|
| Virus Replication | 1 | 2002 | 104 | 0.050 |
Why?
|
| Disease Susceptibility | 2 | 2017 | 179 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 2 | 2002 | 511 | 0.050 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2002 | 133 | 0.050 |
Why?
|
| Gene Transfer Techniques | 1 | 2002 | 173 | 0.050 |
Why?
|
| Fecal Microbiota Transplantation | 1 | 2021 | 17 | 0.050 |
Why?
|
| Isoantigens | 1 | 2021 | 26 | 0.050 |
Why?
|
| Neuropeptides | 1 | 2002 | 106 | 0.050 |
Why?
|
| Immunoglobulin Fragments | 1 | 2000 | 14 | 0.050 |
Why?
|
| Graft vs Leukemia Effect | 1 | 2021 | 33 | 0.050 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2000 | 40 | 0.050 |
Why?
|
| Mice, Inbred DBA | 1 | 2021 | 120 | 0.050 |
Why?
|
| Models, Animal | 1 | 2022 | 252 | 0.050 |
Why?
|
| Allografts | 1 | 2021 | 63 | 0.050 |
Why?
|
| Th17 Cells | 1 | 2021 | 116 | 0.050 |
Why?
|
| Cells, Cultured | 2 | 2017 | 2673 | 0.050 |
Why?
|
| Drug Resistance, Multiple | 1 | 2000 | 56 | 0.040 |
Why?
|
| Drug Resistance, Microbial | 1 | 2000 | 70 | 0.040 |
Why?
|
| Male | 5 | 2022 | 37283 | 0.040 |
Why?
|
| Pregnancy Proteins | 1 | 1999 | 15 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2021 | 852 | 0.040 |
Why?
|
| Multigene Family | 1 | 1999 | 93 | 0.040 |
Why?
|
| Ethanol | 1 | 2005 | 892 | 0.040 |
Why?
|
| Drug Design | 1 | 1999 | 107 | 0.040 |
Why?
|
| Embryo, Mammalian | 1 | 1999 | 176 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2002 | 597 | 0.040 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2021 | 245 | 0.040 |
Why?
|
| Cross Infection | 1 | 2000 | 195 | 0.040 |
Why?
|
| Amino Acid Sequence | 4 | 2002 | 1082 | 0.040 |
Why?
|
| Mice, Knockout | 2 | 2017 | 1692 | 0.040 |
Why?
|
| Female | 6 | 2021 | 38021 | 0.040 |
Why?
|
| Biodiversity | 1 | 2017 | 16 | 0.040 |
Why?
|
| Tooth | 1 | 2017 | 24 | 0.040 |
Why?
|
| Gingiva | 1 | 2017 | 34 | 0.040 |
Why?
|
| Symbiosis | 1 | 2017 | 19 | 0.040 |
Why?
|
| Blotting, Western | 2 | 2014 | 954 | 0.040 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2017 | 38 | 0.040 |
Why?
|
| Hematopoiesis | 1 | 2017 | 108 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2017 | 219 | 0.040 |
Why?
|
| Immunoglobulin A | 1 | 2017 | 79 | 0.040 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2017 | 110 | 0.040 |
Why?
|
| Osteoblasts | 1 | 2017 | 99 | 0.040 |
Why?
|
| RNA | 1 | 2017 | 171 | 0.030 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2017 | 126 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2017 | 396 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 2017 | 217 | 0.030 |
Why?
|
| Cell Proliferation | 2 | 2014 | 1174 | 0.030 |
Why?
|
| Animals, Suckling | 1 | 2015 | 7 | 0.030 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferase 1 | 1 | 2015 | 5 | 0.030 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2015 | 8 | 0.030 |
Why?
|
| Colitis | 1 | 2017 | 156 | 0.030 |
Why?
|
| CpG Islands | 1 | 2015 | 51 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 2014 | 196 | 0.030 |
Why?
|
| Chromatography, Liquid | 1 | 2014 | 120 | 0.030 |
Why?
|
| Bacillus cereus | 1 | 2013 | 3 | 0.030 |
Why?
|
| Time Factors | 2 | 2017 | 4655 | 0.030 |
Why?
|
| Gene Expression Profiling | 2 | 2007 | 498 | 0.030 |
Why?
|
| Species Specificity | 1 | 2013 | 302 | 0.030 |
Why?
|
| Lac Operon | 2 | 2003 | 54 | 0.030 |
Why?
|
| Silent Information Regulator Proteins, Saccharomyces cerevisiae | 1 | 2012 | 7 | 0.030 |
Why?
|
| Sirtuin 2 | 1 | 2012 | 7 | 0.030 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 2012 | 23 | 0.030 |
Why?
|
| DNA, Fungal | 1 | 2012 | 20 | 0.030 |
Why?
|
| Age Factors | 1 | 2017 | 1860 | 0.030 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2014 | 306 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2012 | 137 | 0.030 |
Why?
|
| DNA Replication | 1 | 2012 | 167 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2012 | 208 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 2 | 2002 | 322 | 0.020 |
Why?
|
| Cloning, Molecular | 2 | 2002 | 357 | 0.020 |
Why?
|
| DNA, Complementary | 2 | 2002 | 251 | 0.020 |
Why?
|
| Organophosphates | 1 | 2007 | 7 | 0.020 |
Why?
|
| Aryldialkylphosphatase | 1 | 2007 | 11 | 0.020 |
Why?
|
| Apoptosis | 1 | 2014 | 1641 | 0.020 |
Why?
|
| Protein Array Analysis | 1 | 2007 | 32 | 0.020 |
Why?
|
| Biodegradation, Environmental | 1 | 2007 | 92 | 0.020 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2007 | 58 | 0.020 |
Why?
|
| Mutation | 2 | 2002 | 1213 | 0.020 |
Why?
|
| NADPH Oxidase 2 | 1 | 2005 | 16 | 0.020 |
Why?
|
| Mucous Membrane | 1 | 2005 | 66 | 0.020 |
Why?
|
| Reactive Nitrogen Species | 1 | 2005 | 32 | 0.020 |
Why?
|
| Cell Shape | 1 | 2004 | 37 | 0.020 |
Why?
|
| Methylation | 1 | 2004 | 56 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2005 | 201 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2005 | 411 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2004 | 284 | 0.010 |
Why?
|
| Operator Regions, Genetic | 1 | 2003 | 5 | 0.010 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2003 | 47 | 0.010 |
Why?
|
| Hydrolysis | 1 | 2003 | 144 | 0.010 |
Why?
|
| Histological Techniques | 1 | 2003 | 10 | 0.010 |
Why?
|
| Mouth Diseases | 1 | 2003 | 38 | 0.010 |
Why?
|
| Esophageal Diseases | 1 | 2003 | 95 | 0.010 |
Why?
|
| Water Pollutants, Chemical | 1 | 2007 | 328 | 0.010 |
Why?
|
| Formaldehyde | 1 | 2003 | 48 | 0.010 |
Why?
|
| Paraffin Embedding | 1 | 2003 | 47 | 0.010 |
Why?
|
| Polysaccharides | 1 | 2004 | 176 | 0.010 |
Why?
|
| Mathematical Computing | 1 | 2002 | 12 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2005 | 499 | 0.010 |
Why?
|
| Monosaccharides | 1 | 2002 | 4 | 0.010 |
Why?
|
| Epitope Mapping | 1 | 2002 | 10 | 0.010 |
Why?
|
| Oligosaccharides | 1 | 2002 | 26 | 0.010 |
Why?
|
| Fucose | 1 | 2002 | 25 | 0.010 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2002 | 28 | 0.010 |
Why?
|
| Yeasts | 1 | 2002 | 15 | 0.010 |
Why?
|
| Carbohydrates | 1 | 2002 | 57 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2002 | 88 | 0.010 |
Why?
|
| Rats | 2 | 2002 | 5300 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2002 | 272 | 0.010 |
Why?
|
| Cell Count | 1 | 2002 | 248 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2002 | 77 | 0.010 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2002 | 112 | 0.010 |
Why?
|
| Cell Separation | 1 | 2002 | 132 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2002 | 204 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 2001 | 88 | 0.010 |
Why?
|
| Epitopes | 1 | 2002 | 146 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2002 | 230 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2002 | 237 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2002 | 381 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2003 | 562 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2002 | 220 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2002 | 261 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2002 | 489 | 0.010 |
Why?
|
| Surface Plasmon Resonance | 1 | 2000 | 50 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2002 | 306 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2002 | 214 | 0.010 |
Why?
|
| Stomach Neoplasms | 1 | 2000 | 64 | 0.010 |
Why?
|
| Temperature | 1 | 2001 | 340 | 0.010 |
Why?
|
| Gene Library | 1 | 1999 | 68 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1999 | 95 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2000 | 507 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2000 | 311 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2000 | 376 | 0.010 |
Why?
|
| Peptides | 1 | 2002 | 455 | 0.010 |
Why?
|
| Candidiasis, Vulvovaginal | 1 | 1998 | 9 | 0.010 |
Why?
|
| Carbohydrate Conformation | 1 | 1998 | 25 | 0.010 |
Why?
|
| Carbohydrate Sequence | 1 | 1998 | 45 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 1998 | 124 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2000 | 1174 | 0.010 |
Why?
|
| Models, Biological | 1 | 2002 | 981 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2003 | 2077 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 1998 | 431 | 0.010 |
Why?
|